Latest News about Briefs
Recent news which mentions Briefs
From Benzinga
From Benzinga
EXCLUSIVE: Intelligent Bio Solutions Adds Sixth US Patent For Its Drug Screening Technology
March 26, 2025
From Benzinga
Dollar Tree To Offload Family Dollar Business For $1 Billion, Anticipates 3% To 5% Standalone Same-Store Sales Growth
March 26, 2025
From Benzinga
Asia Markets Mixed, Europe Down As Tariff Concerns Persist - Global Markets Today While US Slept
March 26, 2025
From Benzinga
Bridger Aerospace Expands With Exclusive North American Deal For New Firefighting Aircraft
March 26, 2025
From Benzinga
EXCLUSIVE: Vivani Medical Subdermal Semaglutide Implant Shows 20% Weight Loss In Animal Study, With Potential For Once-Yearly Dosing
March 26, 2025
From Benzinga
From Benzinga
Kroger Files Counterclaims Against Albertsons, Seeks Damages
March 26, 2025
From Benzinga
From Benzinga
From Benzinga
HealthEquity Earns Stock Upgrade Despite Fraud Concerns
March 25, 2025
From Benzinga
Avalo Therapeutics 'Represents An Attractive Pure-Play,' Analyst Initiates Coverage With Over 300% Stock Upside
March 25, 2025
From Benzinga
From Benzinga
From Benzinga
Crinetics Pharmaceuticals Analyst Sees Around 70% Upside For Stock, Cites More Investor Interest In Endocrinology
March 25, 2025
From Benzinga
23andMe's Bankruptcy Sparks Privacy Concerns Over Genetic Database Of 15 Million Customers
March 25, 2025
From Benzinga
From Benzinga
MicroVision's Strategic Moves And New CTO Drive Analyst Confidence, But Challenges Remain In Q4
March 25, 2025
From Benzinga
What's In Store For Comcast This Earnings Season? Analyst Predicts New Pricing Strategies Amid Competitive Pressures
March 25, 2025
From Benzinga
Waystar's Modest FY25 Outlook Faces Growth Challenges: Goldman Sachs Analyst Weighs In
March 25, 2025
From Benzinga
From Benzinga
Merck Partners With Hengrui Pharma In $1.77 Billion Deal For Cardiovascular Treatment
March 25, 2025
From Benzinga
From Benzinga
From Benzinga
Beauty At Your Doorstep: Uber Eats Joins Forces With Sally Beauty For On-Demand Product Delivery
March 25, 2025
From Benzinga
Why Is CrowdStrike Stock Gaining Today?
March 25, 2025
From Benzinga
Axsome Therapeutics Lower Dose Of Attention Deficient Disorder Candidate Hits Primary Goal
March 25, 2025
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.